Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05409443 · ClinicalTrials.gov registry record · Phase 4

Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain

A Phase 4 study of Low Back Pain and Sacroiliac Joint Complex, sponsored by University of Utah.

Recruiting
Registry status
Phase 4
Development phase
116
Enrollment target
3
Study locations

NCT05409443: Recruiting Phase 4 study of Low Back Pain and Sacroiliac Joint Complex, sponsored by University of Utah.

NCT05409443 is a Phase 4 study of Low Back Pain and Sacroiliac Joint Complex that is actively recruiting participants, run by University of Utah. The registered enrollment target is 116 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05409443, a Phase 4 study of Low Back Pain and Sacroiliac Joint Complex, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
Phase 4
Development phase
116 participants
Enrollment target
3
Study locations

Study Summary

Specific Aims The sacroiliac joint complex (SIJC) is a diathrodial, synovial joint and posterior ligamentous network that receives both anterior innervation from the lumbosacral plexus as well as posterior sensory innervation via the posterior sacral network (PSN). The PSN is comprised by the lateral branches S1-S3 posterior rami, with variable contributions from S4 lateral branch, L4 medial branch, and L5 dorsal ramus. Pain signals originating from the SIJC can be interrupted with image-guided percutaneous radiofrequency ablation (RFA) of the PSN, thereby reducing pain and disability in carefully selected patients. A prior systematic review estimated that 32-89% of patients achieve at least 50% pain relief for six months after some type of PSN ablation. Many experts suspect that heterogenous RFA techniques and technology are responsible for the variable success rates seen across published studies. Cadaveric work suggests that targeting the PSN with a large bipolar strip lesions would result in \>95% PSN neural capture compared to a smaller lesion produced by a conventional, monopolar, periforaminal RFA technique which may capture as low as 2.5% of the PSN. Nimbus is a commonly used multi-tined RFA probe whose large bipolar lesion size make it an ideal option for complete PSN neural ablation. Both the Nimbus (N-SIJRFA) and conventional (C-SIJRFA) techniques and technologies are commonly used; however, there are no prospective RCT's comparing them, and the clinical significance remains unknown. Problem: There are no randomized controlled trials comparing novel technologies like N-SIJRFA to C-SIJRFA. Purpose: To compare pain and disability outcomes in patients with confirmed SIJC pain after randomization to either N-SIJRFA or C-SIJRFA. Central Hypothesis: N-SIJRFA will be more effective in improving pain and function compared to patients treated with C-SIJRFA at 3, 6, 12, 18, and 24 months. Specific Aims: 1. Compare the proportion of participants who report ≥50%

Primary Outcome

The number of participants with ≥50% change in their Numeric Pain Rating Scale (NPRS) pain score at the 3-month follow-up assessment. The NPRS is an 11-point numeric scale ranging from 0 to 10, with zero representing "No pain" and ten representing "worst imaginable pain" Using the numbering system, Participants indicate the number that best describes their pain.

Interventions

  • PROCEDURE Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA)
  • PROCEDURE Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA)

Study Locations (3)

Utah

  • University of Utah Farmington Health Center - Farmington
  • University of Utah Orthopaedic Center - Salt Lake City
  • University of Utah South Jordan Health Center - South Jordan

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2022-08-15
Est. Completion 2027-06-30
Phase Phase 4
University of Utah

818 total trials

What NCT05409443 shows while recruiting

NCT05409443 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA) is the first listed.

NCT05409443 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05409443 about?

NCT05409443 is a clinical study titled "Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain". Specific Aims The sacroiliac joint complex (SIJC) is a diathrodial, synovial joint and posterior ligamentous network that receives both anterior innervation from the lumbosacral plexus as well as posterior sensory innervation via the posterior sacral network (PSN). The PSN is comprised by the latera...

What is the current status of trial NCT05409443?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 116 participants. The study started on 2022-08-15. Estimated completion is 2027-06-30.

What conditions does trial NCT05409443 study?

This clinical trial studies the following conditions: Low Back Pain, Sacroiliac Joint Complex.

What interventions are being tested in trial NCT05409443?

The interventions under investigation include: Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA) (PROCEDURE), Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA) (PROCEDURE).

Who is sponsoring clinical trial NCT05409443?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05409443 being conducted?

This trial has 3 study locations across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05409443's enrollment target sits among peer trials

116 52nd of 122 higher than 71 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05409443, the US trial registry maintained by the National Library of Medicine. NCT05409443 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.